000 | 01918 a2200529 4500 | ||
---|---|---|---|
005 | 20250514205430.0 | ||
264 | 0 | _c20050303 | |
008 | 200503s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood-2003-07-2476 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDierksheide, Julie E | |
245 | 0 | 0 |
_aIFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. _h[electronic resource] |
260 |
_bBlood _cFeb 2005 |
||
300 |
_a1558-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Blocking _xpharmacology |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aCell Line, Transformed |
650 | 0 | 4 |
_aCytokines _xgenetics |
650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHerpesvirus 4, Human _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xantagonists & inhibitors |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xantagonists & inhibitors |
700 | 1 | _aBaiocchi, Robert A | |
700 | 1 | _aFerketich, Amy K | |
700 | 1 | _aRoychowdhury, Sameek | |
700 | 1 | _aPelletier, Ronald P | |
700 | 1 | _aEisenbeis, Charles F | |
700 | 1 | _aCaligiuri, Michael A | |
700 | 1 | _aVanBuskirk, Anne M | |
773 | 0 |
_tBlood _gvol. 105 _gno. 4 _gp. 1558-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2003-07-2476 _zAvailable from publisher's website |
999 |
_c15188305 _d15188305 |